NEW YORK: An injection of cash that values Facebook at US$50 billion will help it delay going public for at least another year, giving the company breathing room to focus on long-term ambition rather than short-term profit.
The infusion - $500 million from elite investment house Goldman Sachs and a Russian investor, according to a report by The New York Times - represents the most emphatic endorsement yet of Facebook's potential to make money in online social networking.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
